This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huynh, H. Articles by Pollak, M. Search for Related Content PubMed PubMed Citation Articles by Huynh, H. Articles by Pollak, M.

Uterotrophic Actions of Estradiol and Tamoxifen Are Associated with Inhibition of Uterine Insulin-like Growth Factor Binding Protein 3 Gene Expression¹

Lady Davis Research Institute of the Jewish General Hospital, and McGill University, Montreal, Quebec H3T 1E2, Canada

We have recently shown that uterine insulin-like growth factor I (IGF-I) gene expression is up-regulated by tamoxifen, a uterotrophic partial antagonist to the estrogen receptor, but down-regulated by the complete estrogen receptor antagonist ICI 182780, which causes uterine involution. This result is consistent with prior reports indicating that the uterotrophic effects of estradiol are mediated at least in part by estradiolstimulated uterine IGF-I gene expression. We demonstrate here that the uterotrophic agents estradiol and tamoxifen each suppress expression of the IGF binding protein 3 (IGFBP-3) gene in uterus to less than one-third of control values, while oophorectomy or administration of the complete estrogen receptor antagonist ICI 182780, both of which result in uterine involution, are associated with a greater than 3-fold stimulation of uterine IGFBP-3 gene expression. The data reveal a negative correlation between uterine weight and uterine IGFBP-3 gene expression as well as reciprocal regulation by estradiol of expression in uterus of the genes encoding IGF-I and IGFBP-3. In vitro, IGFBP-3 protein accumulation in media conditioned by primary uterine cultures was decreased by estradiol treatment and increased by ICI 182780 treatment. Together, these observations provide a novel mechanism by which estradiol and antiestrogens modulate uterine IGF-I physiology that is consistent with the view that the mitogenic activity of IGF-I is reduced in the presence of IGFBP-3. The uterotrophic toxicity of chronic estradiol or tamoxifen treatment may be causally related to both the inhibition of uterine IGFBP-3 expression and the stimulation of uterine IGF-I expression by these compounds.

¹ Supported by grants from the Riesman Family Foundation and the National Cancer Institute of Canada (to M. P.).

² To whom requests for reprints should be addressed, at Lady Davis Research Institute of the Jewish General Hospital, 3755 Cote St. Catherine, Montreal, Quebec H3T 1E2, Canada.

Received 3/21/94. Accepted 5/ 3/94.

This article has been cited by other articles:

				H. Hung Suppression of ps20 Expression in the Rat Uterus by Tamoxifen and Estrogens Endocrinology, May 1, 2005; 146(5): 2388 - 2396. [Abstract] [Full Text] [PDF]

				J. H. Lai, D. Vesprini, W. Zhang, M. J. Yaffe, M. Pollak, and S. A. Narod A Polymorphic Locus in the Promoter Region of the IGFBP3 Gene Is Related to Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 573 - 582. [Abstract] [Full Text] [PDF]

				T. W. Chan, M. Pollak, and H. Huynh Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780 Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554. [Abstract] [Full Text] [PDF]

				H. Huynh, C. Y. Ng, K. B. Lim, C. K. Ong, C. S. Ong, E. Tran, T. T. Tuyen Nguyen, and T. W. M. G. Chan Induction of UO-44 Gene Expression by Tamoxifen in the Rat Uterus and Ovary Endocrinology, July 1, 2001; 142(7): 2985 - 2995. [Abstract] [Full Text] [PDF]

				B. Sukhu, B. Rotenberg, C. Binkert, H. Kohno R. ZOHAR, C. A. G. McCulloch, and H. C. Tenenbaum Tamoxifen Attenuates Glucocorticoid Actions on Bone Formation in Vitro Endocrinology, August 1, 1997; 138(8): 3269 - 3275. [Abstract] [Full Text] [PDF]

				H. Huynh, X. Yang, and M. Pollak Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer Cells J. Biol. Chem., January 12, 1996; 271(2): 1016 - 1021. [Abstract] [Full Text] [PDF]

				P Neven, X D Muylder, Y V Belle, R Campo, and G Vanderick Tamoxifen and the uterus BMJ, November 19, 1994; 309(6965): 1313 - 1314. [Full Text]

				M McKee On advising politicians BMJ, May 21, 1994; 308(6940): 1313 - 1313. [Full Text]